Literature DB >> 23782391

A common pathway for O-linked protein-glycosylation and synthesis of capsule in Acinetobacter baumannii.

Robert G Lees-Miller1, Jeremy A Iwashkiw, Nichollas E Scott, Andrea Seper, Evgeny Vinogradov, Stefan Schild, Mario F Feldman.   

Abstract

Multi-drug resistant strains of Acinetobacter baumannii are increasingly being isolated in hospitals worldwide. Among the virulence factors identified in this bacterium there is a general O-glycosylation system that appears to be important for biofilm formation and virulence, and the capsular polysaccharide, which is essential for resistance to complement killing. In this work, we identified a locus that is responsible for the synthesis of the O-pentasaccharide found on the glycoproteins. Besides the enzymes required for the assembly of the glycan, additional proteins typically involved in polymerization and transport of capsule were identified within or adjacently to the locus. Mutagenesis of PglC, the initiating glycosyltransferase prevented the synthesis of both glycoproteins and capsule, resulting in abnormal biofilm structures and attenuated virulence in mice. These results, together with the structural analysis of A. baumannii 17978 capsular polysaccharide via NMR, demonstrated that the pentasaccharides that decorate the glycoproteins are also the building blocks for capsule biosynthesis. Two linked subunits, but not longer glycan chains, were detected on proteins via MS. The discovery of a bifurcated pathway for O-glycosylation and capsule synthesis not only provides insight into the biology of A. baumannii but also identifies potential novel candidates for intervention against this emerging pathogen.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23782391     DOI: 10.1111/mmi.12300

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  58 in total

1.  K2 Capsule Depolymerase Is Highly Stable, Is Refractory to Resistance, and Protects Larvae and Mice from Acinetobacter baumannii Sepsis.

Authors:  Hugo Oliveira; Ana Mendes; Alexandra G Fraga; Alice Ferreira; Andreia I Pimenta; Dalila Mil-Homens; Arsénio M Fialho; Jorge Pedrosa; Joana Azeredo
Journal:  Appl Environ Microbiol       Date:  2019-08-14       Impact factor: 4.792

2.  Structural Diversity in the Type IV Pili of Multidrug-resistant Acinetobacter.

Authors:  Kurt H Piepenbrink; Erik Lillehoj; Christian M Harding; Jason W Labonte; Xiaotong Zuo; Chelsea A Rapp; Robert S Munson; Simeon E Goldblum; Mario F Feldman; Jeffrey J Gray; Eric J Sundberg
Journal:  J Biol Chem       Date:  2016-09-15       Impact factor: 5.157

Review 3.  Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Authors:  Yohei Doi; Gerald L Murray; Anton Y Peleg
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

Review 4.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

5.  Functional Analysis and Antivirulence Properties of a New Depolymerase from a Myovirus That Infects Acinetobacter baumannii Capsule K45.

Authors:  Hugo Oliveira; Ana Rita Costa; Alice Ferreira; Nico Konstantinides; Sílvio B Santos; Maarten Boon; Jean-Paul Noben; Rob Lavigne; Joana Azeredo
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

Review 6.  The sweet tooth of bacteria: common themes in bacterial glycoconjugates.

Authors:  Hanne L P Tytgat; Sarah Lebeer
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

Review 7.  Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond.

Authors:  Brent S Weber; Christian M Harding; Mario F Feldman
Journal:  J Bacteriol       Date:  2015-12-28       Impact factor: 3.490

8.  Dual Role of gnaA in Antibiotic Resistance and Virulence in Acinetobacter baumannii.

Authors:  Qingye Xu; Tao Chen; Biyong Yan; Linyue Zhang; Borui Pi; Yunxing Yang; Linghong Zhang; Zhihui Zhou; Shujuan Ji; Sebastian Leptihn; Murat Akova; Yunsong Yu; Xiaoting Hua
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

Review 9.  Expanding the paradigm for the outer membrane: Acinetobacter baumannii in the absence of endotoxin.

Authors:  Matthew Joseph Powers; M Stephen Trent
Journal:  Mol Microbiol       Date:  2017-11-20       Impact factor: 3.501

Review 10.  Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity.

Authors:  A M Richards; Y Abu Kwaik; R J Lamont
Journal:  Mol Oral Microbiol       Date:  2014-09-27       Impact factor: 3.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.